Yuxi Walvax Biotechnology Co., Ltd.

About Yuxi Walvax Biotechnology Co., Ltd.

Founded in 2001, Walvax Biotechnology Co. Ltd. is mainly engaged in research and development, manufacturing and distribution of safe and efficacious human vaccines. Walvax is a leading public listed company in China and has successfully developed 9 licensed vaccines (13 presentations). Among the 9 licensed products, Walvax has world’s 2nd approved PCV-13, 4th approved mRNA Covid-19 vaccine and 5th approved HPV vaccine. 

  • Country/Region:
    China
  • On CPHI since:
    2023
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
Contact info
Meet us at

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026

Products from Yuxi Walvax Biotechnology Co., Ltd. (3)